Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 24(6):929-936
- Year
- 2006
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321
- Journal / Conference
- Journal of the National Cancer Institute 98(8):529-534
- Year
- 2006
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology 24(18):2828-2835
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9916
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel/estramustine to mitoxantrone/prednisone
- Journal / Conference
- Cancer 106(12):2624-2629
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0207
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies
- Journal / Conference
- Cancer 107(3):489-496
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)
The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: a multivariate analysis of Southwest Oncology Group study 8894
- Journal / Conference
- Oncology Reports 16:807-810
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9458
Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group study
- Journal / Conference
- Journal of the American Medical Association 296(19):2329-2335
- Year
- 2006
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794
Adjuvant radiotherapy for pathologically-advanced prostate cancer: a randomized, clinical trial
- Journal / Conference
- Journal of Clinical Oncology 24(30):4922-4927
- Year
- 2006
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0127
Phase II trial of erlotinib in gastoresophageal junction and gastric adenocarcinomas: SWOG 0127
- Journal / Conference
- Journal of Clinical Oncology 24(25):4143-4149
- Year
- 2006
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9911